Copeland Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.8M | Sell |
21,606
-76
| -0.4% | -$59.2K | 0.35% | 96 |
|
2025
Q1 | $17.9M | Sell |
21,682
-410
| -2% | -$339K | 0.36% | 94 |
|
2024
Q4 | $17.1M | Sell |
22,092
-3,277
| -13% | -$2.53M | 0.32% | 96 |
|
2024
Q3 | $22.5M | Sell |
25,369
-994
| -4% | -$881K | 0.39% | 92 |
|
2024
Q2 | $23.9M | Buy |
26,363
+886
| +3% | +$802K | 0.45% | 85 |
|
2024
Q1 | $19.8M | Buy |
25,477
+1,900
| +8% | +$1.48M | 0.36% | 87 |
|
2023
Q4 | $13.7M | Buy |
23,577
+9,318
| +65% | +$5.43M | 0.28% | 96 |
|
2023
Q3 | $7.66M | Sell |
14,259
-340
| -2% | -$183K | 0.16% | 112 |
|
2023
Q2 | $6.85M | Buy |
14,599
+13,217
| +956% | +$6.2M | 0.14% | 112 |
|
2023
Q1 | $475K | Hold |
1,382
| – | – | 0.01% | 129 |
|
2022
Q4 | $506K | Hold |
1,382
| – | – | 0.01% | 131 |
|
2022
Q3 | $447K | Hold |
1,382
| – | – | 0.01% | 129 |
|
2022
Q2 | $448K | Hold |
1,382
| – | – | 0.01% | 129 |
|
2022
Q1 | $396K | Hold |
1,382
| – | – | 0.01% | 126 |
|
2021
Q4 | $382K | Hold |
1,382
| – | – | 0.01% | 128 |
|
2021
Q3 | $319K | Hold |
1,382
| – | – | 0.01% | 131 |
|
2021
Q2 | $317K | Hold |
1,382
| – | – | 0.01% | 132 |
|
2021
Q1 | $258K | Hold |
1,382
| – | – | 0.01% | 135 |
|
2020
Q4 | $233K | Hold |
1,382
| – | – | 0.01% | 133 |
|
2020
Q3 | $205K | Hold |
1,382
| – | – | 0.01% | 123 |
|
2020
Q2 | $227K | Hold |
1,382
| – | – | 0.01% | 121 |
|
2020
Q1 | $192K | Hold |
1,382
| – | – | 0.01% | 124 |
|
2019
Q4 | $182K | Hold |
1,382
| – | – | 0.01% | 140 |
|
2019
Q3 | $155K | Hold |
1,382
| – | – | 0.01% | 138 |
|
2019
Q2 | $153K | Hold |
1,382
| – | – | 0.01% | 141 |
|
2019
Q1 | $179K | Sell |
1,382
-218
| -14% | -$28.2K | 0.01% | 134 |
|
2018
Q4 | $185K | Buy |
+1,600
| New | +$185K | 0.01% | 133 |
|